In this video by Neurology Today learn more about neuroimaging.
Individuals with mutations in the superoxide dismutase 1 (SOD1) gene develop brain white matter abnormalities before the onset of symptoms of amyotrophic lateral sclerosis (ALS), according to a new imaging study that was presented at the 2014 AAN annual meeting.
In a panel discussion, Neurology Today Editor-in-chief Steven P. Ringel, MD, and Neurology Today Associate Editor Robert G. Holloway Jr., MD, MPH, spoke with Joseph C. Masdeu, MD, PhD, director of the Nantz National Alzheimer Center, about what these findings may signify for ALS experts and patients, and how neuroimaging could potentially improve ALS care and diagnosis in the future.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?